A PIPELINE POWERED BYPASSION
PUBLICATIONS AND PRESENTATIONS
The Effect of Omecamtiv Mecarbil on Exercise Capacity in Chronic Heart Failure with Reduced Ejection Fraction: The METEORIC-HF Study
Presentation, American College of Cardiology 71st Annual Scientific Session
Felker GM, et al
Washington, D.C.
April 3, 2022
The Effect of Omecamtiv Mecarbil in Hospitalized Patients as Compared with Outpatients
Poster, American College of Cardiology 71st Annual Scientific Session (ACC.22)
Docherty KF, et al
Washington, D.C.
April 3, 2022
Healthcare Resource Use, Intensity, and Costs Among Patients with Heart Failure with Reduced Ejection Fraction Treated with Omecamtiv Mecarbil in GALACTIC-HF
Poster, American College of Cardiology 71st Annual Scientific Session (ACC.22)
Desai NR, et al
Washington, D.C.
April 3, 2022
REDWOOD-HCM Cohort 3: Evidence for Clinical Efficacy of Aficamten in Patients with Obstructive HCM and HF Symptoms Refractory to Maximal Medical Therapy, Including Disopyramide
Poster, American College of Cardiology 71st Annual Scientific Session (ACC.22)
Owens AT, et al
Washington, D.C.
April 2, 2022
Influence of Atrial Fibrillation on Efficacy and Safety of Omecamtiv Mecarbil in Heart Failure: the GALACTIC-HF Trial
European Heart Journal
Solomon SD, Claggett BL, Miao ZM, et al
March 23, 2022